PEAK6
DNA icon

PEAK6’s Ginkgo Bioworks DNA Stock Holding History

PEAK6’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.2K Sell
1,500
-19,300
-93% -$161K ﹤0.01% 2539
2025
Q4 		$173K Buy
+20,800
New +$224K ﹤0.01% 2416

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PEAK6's DNA Position: Q1 2026 in Review

PEAK6 reduced its Ginkgo Bioworks (DNA) stake by 34% in Q1 2026, selling an estimated $463K and leaving 107,163 shares worth $657K. The position accounts for ﹤0.01% of the portfolio, ranked #1869.

PEAK6 first reported a position in DNA in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.35M in Q4 2025. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • PEAK6 held 107,163 shares of Ginkgo Bioworks worth $657K as of Q1 2026.
  • PEAK6 sold 55,674 Ginkgo Bioworks shares in Q1 2026, an estimated $463K.
  • Ginkgo Bioworks made up ﹤0.01% of PEAK6's portfolio in Q1 2026, its #1869 holding.
  • PEAK6 first reported a position in Ginkgo Bioworks in Q4 2025 and has held it in 2 quarters since.
  • PEAK6's Ginkgo Bioworks position peaked at $1.35M in Q4 2025.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.